A Survey of Experiences and Opinions Regarding Skin Toxicities Associated with Vectibix Among mCRC Patients

First published 30/07/2019

Last updated 11/11/2020

EU PAS number:

EUPAS30334

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

csr-20190025-protocol_public-redacted-approved-version

English (926.35 KB - PDF)View document

Study results

Study results

20190025_Adelphi ORSR_08.24.20_abstract (002)_Redacted

English (38.69 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents